CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE

Financial Highlights - Total revenues for the second quarter of 2025 reached $98.9 billion, an increase of 8.4% compared to the prior year [4][7] - Operating income decreased by 21.8% to $2.4 billion, primarily due to $833 million in litigation charges [8] - Adjusted operating income increased by 1.7% to $3.8 billion, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments [8] - Diluted earnings per share (EPS) were $0.80, down from $1.41 in the prior year, while adjusted EPS was $1.81, relatively stable compared to the previous year [4][7] Operational Highlights - The Health Care Benefits segment reported total revenues of $36.3 billion, up from $32.5 billion, with adjusted operating income increasing significantly [10] - The Health Services segment's total revenues rose to $46.5 billion, but adjusted operating income decreased due to litigation charges [12] - The Pharmacy & Consumer Wellness segment saw total revenues increase to $33.6 billion, with adjusted operating income rising significantly [16] 2025 Full-Year Guidance - The company revised its GAAP diluted EPS guidance range to $3.84 to $3.94, down from $4.23 to $4.43 [7] - Adjusted EPS guidance was raised to a range of $6.30 to $6.40, up from $6.00 to $6.20 [7] - Cash flow from operations guidance was increased to at least $7.5 billion, up from approximately $7.0 billion [7] CEO Commentary - The CEO emphasized the company's commitment to providing a connected and simpler health care experience, highlighting strong performance across various segments [1][2] - The focus remains on operational and financial improvement, particularly in the Aetna and CVS Caremark segments [1][5] Additional Insights - The company announced a commitment of $20 billion over the next decade to simplify the U.S. health system [13] - CVS Pharmacy agreed to acquire certain prescription files and store locations from Rite Aid, enhancing its market position [13] - The company is actively working on initiatives to improve the experience for both doctors and patients [13]